|
1
|
Chiaretti A, Aloe L, Antonelli A, Ruggiero
A, Piastra M, Riccardi R, Tamburrini G and Di Rocco C: Neurotrophic
factor expression in childhood low-grade astrocytomas and
ependymomas. Childs Nerv Syst. 20:412–419. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aloe L, Tirassa P and Bracci-Laudiero L:
Nerve growth factor in neurological and non-neurological diseases:
Basic findings and emerging pharmacological prospectives. Curr
Pharm Des. 7:113–123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Drago J, Kilpatrick TJ, Koblar SA and
Talman PS: Growth factor: Potential therapeutic applications in
neurology. J Neurol Neurosurg Psychiatry. 57:1445–1450. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Levi-Montalcini R: The nerve growth factor
35 years later. Science. 237:1154–1162. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thoenen H, Bandtlow C and Heumann R: The
physiological function of nerve growth factor in the central
nervous system: Comparison with the periphery. Rev Physiol Biochem
Pharmacol. 109:145–178. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barde YA: Neurotrophins: A family of
proteins supporting the survival of neurons. Prog Clin Biol Res.
390:45–56. 1994.PubMed/NCBI
|
|
7
|
Sofroniew MV, Howe CL and Mobley WC: Nerve
growth factor signaling, neuroprotection, and neural repair. Annu
Rev Neurosci. 24:1217–1281. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Korsching S, Auburger G, Heumann R, Scott
J and Thoenen H: Levels of nerve growth factor and its mRNA in the
central nervous system of the rat correlate with cholinergic
innervation. Embo J. 4:1389–1393. 1985.PubMed/NCBI
|
|
9
|
Connor B and Dragunow M: The role of
neuronal growth factors in neurodegenerative disorders of the human
brain. Brain Res Brain Res Rev. 27:1–39. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Levi-Montalcini A and Angeletti PU: Nerve
growth factor. Physiol Rev. 48:534–569. 1968.PubMed/NCBI
|
|
11
|
Chao MV and Hempstead BL: p75 and Trk: A
two-receptor system. Trends Neurosci. 18:321–326. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Yang Y, Gong A, Wang C, Liang Y
and Chen Y: Localization of NGF and TrkA at mitotic apparatus in
human astrocytoma cell line u251. Biochem Biophys Res Commun.
337:68–74. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Friedman WJ, Ibáñez CF, Hallböök F,
Persson H, Cain LD, Dreyfus CF and Black IB: Differential actions
of neurotrophins in the locus corelueus and basal forebrain. Exp
Neurol. 119:72–78. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mamounas LA, Blue ME, Siuciak JA and Altar
CA: Brain-derived neurotrophic factor promotes the survival and
sprouting of serotonergic axons in rat brain. J Neurosci.
15:7929–7939. 1995.PubMed/NCBI
|
|
15
|
Siuciak JA, Altar CA, Wiegand SJ and
Lindsay RM: Antinociceptive effect of brain-derived neurotrophic
factor and neurotrophin-3. Brain Res. 633:326–330. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sklair-Tavron L and Nestler EJ: Opposing
effects of morphine and the neurotrophins, NT-3, NT-4, and BDNF, on
locus coeruleus neurons in vitro. Brain Res. 702:117–125. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Juric DM, Miklic S and Carman-Krzan M:
Monoaminergic neuronal activity up-regulates BDNF synthesis in
cultured neonatal rat astrocytes. Brain Res. 1108:54–62. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baloh RH, Enomoto H, Johnson EM Jr and
Milbrandt J: The GDNF family ligands and receptors-implications for
neural development. Curr Opin Neurobiol. 10:103–110. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang ZF, Ho DW, Lau CK, Tam KH, Lam CT, Yu
WC, Poon RT and Fan ST: Significance of the serum brain-derived
neurotrophic factor and platelets in hepatocellular carcinoma.
Oncol Rep. 16:1237–1243. 2006.PubMed/NCBI
|
|
20
|
Tapia-Arancibia L, Rage F, Givalois L and
Arancibia S: Physiology of BDNF: Focus on hypothalamic function.
Front Neuroendocrinol. 25:77–107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsumoto K, Yamamoto K, Karasawa Y, Hino
N, Nakamura A, Takahashi M, Araki H, Okuyama S, Choshi T, Sugino E,
et al: Possible involvement of induction of brain-derived
neurotrophic factor in the neuroprotective effect of a
5-phenylpyrimidine derivative. Biochem Pharmacol. 66:1019–1023.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Renné C, Willenbrock K, Küppers R,
Hansmann ML and Bräuninger A: Autocrine and paracrine-activated
receptor tyrosine kinases in classic hodgkin lymphoma. Blood.
105:4051–4059. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pearse RN, Swendeman SL, Li Y, Rafii D and
Hempstead BL: A neurotrophin axis in myeloma: TrkB and BDNF promote
tumor-cell survival. Blood. 105:4429–4436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Douma S, Van Laar T, Zevenhoven J,
Meuwissen R, Van Garderen E and Peeper DS: Suppression of anoikis
and induction of metastasis by the neurotrophic receptor TrkB.
Nature. 430:1034–1039. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grotzer MA, Janss AJ, Fung K, Biegel JA,
Sutton LN, Rorke LB, Zhao H, Cnaan A, Phillips PC, Lee VM and
Trojanowski JQ: TrkC expression predicts good clinical outcome in
primitive neuroectodermal brain tumors. J Clin Oncol. 18:1027–1035.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Segal RA, Goumnerova LC, Kwon YK, Stiles
CD and Pomeroy SL: Expression of the neurotrophin receptor TrkC is
linked to a favorable outcome in medulloblastoma. Proc Natl Acad
Sci USA. 91:pp. 12867–12871. 1994; View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiappa SA, Chin LS, Zurawel RH and Raffel
C: Neurotrophins and Trk receptors in primitive neuroectodermal
tumor cell lines. Neurosurgery. 45:1148–1155. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colucci-D'Amato GL, D'Alessio A, Califano
D, Cali G, Rizzo C, Nitsch L, Santelli G and de Franciscis V:
Abrogation of nerve growth factor-induced terminal differentiation
by ret oncogene involves perturbation of nuclear translocation of
ERK. J Biol Chem. 275:19306–19314. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Devouassoux-Shisheboran M, Mauduit C,
Tabone E, Droz JP and Benahmed M: Growth regulatory factors and
signalling proteins in testicular germ cell tumours. APMIS.
111:212–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eggert A, Sieverts H, Ikegaki N and
Brodeur GM: P75 mediated apoptosis in neuroblastoma cells is
inhibited by expression of TrkA. Med Pediatr Oncol. 35:573–576.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goustin AS, Leof EB, Shipley GD and Moses
HL: Growth factors and cancer. Cancer Res. 46:1015–1029.
1986.PubMed/NCBI
|
|
32
|
Nishio S, Morioka T, Hamada Y, Fukui M and
Nakagawara A: Immunohistochemical expression of tyrosine kinase
(Trk) receptor proteins in mature neuronal cell tumors of the
central nervous system. Clin Neuropathol. 17:123–130.
1998.PubMed/NCBI
|
|
33
|
Zhu Z, Friess H, diMola FF, Zimmermann A,
Graber HU, Korc M and Büchler MW: Nerve growth factor expression
correlates with perineural invasion and pain in human pancreatic
cancer. J Clin Oncol. 17:2419–2428. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu ZW, Friess H, Wang L, Di Mola FF,
Zimmermann A and Büchler MW: Down-regulation of nerve growth factor
in poorly differentiated and advanced human esophageal cancer.
Anticancer Res. 20:125–132. 2000.PubMed/NCBI
|
|
35
|
Dollé L, ElYazidi-Belkoura I, Adriaenssens
E, Nurcombe V and Hondermarck H: Nerve growth factor overexpression
and autocrine loop in breast cancer cells. Oncogene. 22:5592–5601.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Breit S, Ashman K, Wilting J, Rössler J,
Hatzi E, Fotsis T and Schweigerer L: The N-myc oncogene in human
neuroblastoma cells: Down-regulation of an angiogenesis inhibitor
identified as activin. Cancer Res. 60:4596–4601. 2000.PubMed/NCBI
|
|
37
|
Zhang J, Zhang J, Li A and Fan Y: Role of
nerve growth factor receptor in neuroblastoma angiogenesis. Chinese
J Contemporary Pediatrics. 6:93–98. 2004.
|
|
38
|
Hu Y, Sun CY, Wang HF, Guo T, Wei WN, Wang
YD, He WJ, Wu T, Tan H and Wu TC: Brain-derived neurotrophic factor
promotes growth and migration of multiple myeloma cells. Cancer
Genet Cytogenet. 169:12–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qiu L, Zhou C, Sun Y, Di W, Scheffler E,
Healey S, Kouttab N, Chu W and Wan Y: Crosstalk between EGFR and
TrkB enhances ovarian cancer cell migration and proliferation. Int
J Oncol. 29:1003–1011. 2006.PubMed/NCBI
|
